EMEA-002935-PIP01-20-M03 - paediatric investigation plan

Idrevloride

Key facts

• Active Substance:
  Idrevloride
• Therapeutic area:
  Pneumology-allergology
• Decision number:
  P/0165/2023
• PIP number:
  EMEA-002935-PIP01-20-M03
• Pharmaceutical form(s):
  Inhalation solution
• Condition(s) / indication(s):
  Treatment of primary ciliary dyskinesia
• Route(s) of administration:
  Inhalation use
• Contact for public enquiries:

  Parion Sciences, Inc.

  E-mail: [e-mail]; Tel: [phone]

• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  15/05/2023

Decision

P/0165/2023 : EMA decision of 15 May 2023 on the acceptance of a modification of an agreed paediatric investigation plan for idrevloride (EMEA- 002935-PIP01-20-M03)

Reference Number: EMA/160446/2023